why choose us

First received: August 24, 2023

Clinical Trial: Tocilizumab in Lung Transplantation

Study Status: Completed

Recruit Status: RECRUITING

Condition: Lung Transplant

Study Type: INTERVENTIONAL


Official Title: Targeting Inflammation and Alloimmunity in Lung Transplant Recipients With Tocilizumab (CTOT-45)

Brief Summary: This is a trial in which 350 primary lung transplant recipients will be randomized (1:1) to receive either Tocilizumab (six doses over 20 weeks) plus standard triple maintenance immunosuppression or placebo (sterile normal saline) plus standard triple maintenance immunosuppression (Tacrolimus, Mycophenolate Mofetil, corticosteroids).The primary objective is to test the hypothesis that treatment with triple maintenance immunosuppression plus Tocilizumab (TCZ) is superior to triple maintenance immunosuppression plus…

Read more